| A Digital Tool to Contextualise the Benefit Risk of COVID-19 Vaccines in the European Union: The Benefit Risk Assessment of Vaccines (BRAVE) Toolkit HG Dorta, J Verbeeck, J Crevecoeure, D Morales, N Loedy, C Cohet, ... | | 2023 |
| A Digital Tool to Contextualise the Benefit Risk of COVID-19 Vaccines in the European Union: The Benefit Risk Assessment of Vaccines (BRAVE) Toolkit H Gonzalez Dorta, J Verbeeck, J Crevecoeure, D Morales, N Loedy, ... Available at SSRN 4491619, 0 | | |
| A digital toolkit to contextualize and visualize the benefit and risk of COVID-19 vaccines in the European union HG Dorta, C Quinten, DRM Leaver, C Cohet, G Molenberghs, N Hens, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 32, 298-299, 2023 | | 2023 |
| A feasibility assessment of real‐world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a … S Welby, Y Feng, H Tang, C Ye, C Cohet Pharmacoepidemiology and Drug Safety 32 (10), 1131-1141, 2023 | | 2023 |
| A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian … C Cohet, B Cheuvart, L Moerman, D Bi, A Caplanusi, M Kariyappa, ... Human Vaccines & Immunotherapeutics 17 (11), 4646-4653, 2021 | 1 | 2021 |
| A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD® P Bonanni, C Cohet, SK Kjaer, NB Latham, PH Lambert, K Reisinger, ... Vaccine 28 (30), 4719-4730, 2010 | 68 | 2010 |
| Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study S Bourne, C Cohet, V Kim, A Barton, A Tuck, E Aris, S Mesia-Vela, ... BMJ open 4 (3), e004546, 2014 | 27 | 2014 |
| Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study (vol 4, e004546 2014) S Bourne, C Cohet, V Kim BMJ OPEN 5 (1), 2015 | | 2015 |
| Adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccines and solid organ transplant rejection: systematic signal evaluation and lessons learnt G Dos Santos, HA Seifert, V Bauchau, V Shinde, DM Barbeau, C Cohet Drug safety 40, 693-702, 2017 | 10 | 2017 |
| Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™and Narcolepsy K Bollaerts, V Shinde, G Dos Santos, G Ferreira, V Bauchau, C Cohet, ... PloS one 11 (2), e0149289, 2016 | 13 | 2016 |
| Applying the test-negative design to vaccine safety studies: risk of narcolepsy associated with A/H1N1 (2009) pandemic influenza vaccination in Quebec C Cohet, J Montplaisir, D Petit, MJ Quinn, M Ouakki, G Deceuninck, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 24, 406-407, 2015 | 6 | 2015 |
| Assessing heterogeneity of electronic health‐care databases: A case study of background incidence rates of venous thromboembolism M Russek, C Quinten, VMT de Jong, C Cohet, X Kurz Pharmacoepidemiology and Drug Safety 32 (9), 1032-1048, 2023 | 4 | 2023 |
| Association between rotavirus gastroenteritis and intussusception: suggested evidence from a retrospective study in claims databases in the United States C Willame, B Cheuvart, E Aris, V Vetter, C Cohet Human Vaccines & Immunotherapeutics 17 (1), 269-277, 2021 | 7 | 2021 |
| Benefit risk contextualization of COVID-19 vaccines in the EU X Kurz, C Cohet, C Quinten, G Molenberghs, N Hens, S Abrams, L Willem, ... Pharmacoepidemiology And Drug Safety 31, 135-136, 2022 | | 2022 |
| Ceinture africaine de la méningite: De la génomique aux stratégies de surveillance, de lutte et de prévention JM Alonso, É Bertherat, W Perea, R Borrow, S Chanteau, C Cohet, ... Bulletin de la Societe de Pathologie Exotique 99 (5), 404-408, 2006 | 4 | 2006 |
| Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view C Cohet, D Rosillon, C Willame, F Haguinet, MN Marenne, S Fontaine, ... Vaccine 35 (23), 3041-3049, 2017 | 8 | 2017 |
| Comparative effectiveness of heterologous booster schedules with AZD1222, BNT162b2, or mRNA-1273 vaccines against COVID-19 during omicron predominance in the Nordic countries NW Andersson, EM Thiesson, U Baum, N Pihlström, J Starrfelt, K Faksová, ... MedRxiv, 2022.11. 24.22282651, 2022 | 2 | 2022 |
| Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses NW Andersson, EM Thiesson, U Baum, N Pihlström, J Starrfelt, K Faksová, ... bmj 382, 2023 | 10 | 2023 |
| Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five … X Li, E Burn, T Duarte-Salles, C Yin, C Reich, A Delmestri, K Verhamme, ... bmj 379, 2022 | 28 | 2022 |
| COMPTE-RENDUS DE CONGRÈS JM Alonso, E Bertherat, W Perea, R Borrow, S Chanteau, C Cohet, ... Bull Soc Pathol Exot 99 (5), 404-408, 2006 | 1 | 2006 |
Tom WilkinsonUniversity of Southampton在 soton.ac.uk 的电子邮件经过验证
